A 33-Year-Old Woman with Jaundice after Azithromycin Use

Arief Suriawinata; Albert D. Min

doi:10.1055/s-2002-30107

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2002; 22(2): 207-210
DOI: 10.1055/s-2002-30107

DIAGNOSTIC PROBLEMS IN HEPATOLOGY

A 33-Year-Old Woman with Jaundice after Azithromycin Use

Arief Suriawinata¹ , Albert D. Min²

¹Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York
²Division of Liver Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York

Abstract

Full Text

References

REFERENCES

1 Longo G, Valenti C, Gandini G. Azithromycin-induced intrahepatic cholestasis. Am J Med . 1997; 102 217-218
2 Macaigne G, Mokbel M, Marty O. Acute pseudoangiocholitic hepatitis probably induced by azithromycin. Gastroenterol Clin Biol . 2000; 24 969-970
3 Diehl A M, Latham P, Boinott J K. Cholestatic hepatitis from erythromycin ethylsuccinate. Am J Med . 1984; 76 931-934
4 Keeffe E B, Reis T C, Berland J E. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate. Dig Dis Sci . 1982; 27 701-704
5 Zafrani E S, Ishak K G, Rudzki C. Cholestatic and hepatocellular injury associated with erythromycin esters. Report of nine cases. Dig Dis Sci . 1979; 24 385-396
6 Periti P, Mazze T, Mini E. Adverse effects of macrolide antibacterials. Drug Saf . 1993; 9 346-364
7 Danan G, Descatoire V, Pessayre D. Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. J Pharmacol Exp Ther . 1981; 218 509-514
8 Chitturi S, Farrell G. Drug-induced cholestasis. Sem Gastrointest Dis . 2001; 12 113-124
9 Lalak N J, Morris D L. Azithromycin clinical pharmacokinetics. Clin Pharmacokinet . 1993; 25 370-374
10 Westphal J F, Vetter D, Brogard J M. Hepatic side-effects of antibiotics. J Antimicrob Chemother . 1994; 33 387-401
11 Orellana-Alcalde J M, Dominguez J P. Jaundice and oral contraceptive drugs. Lancet . 1966; 2 1279-1280
12 Metreau J M, Chumeaux D, Berthelot P. Oral contraceptives and the liver. Digestion . 1972; 7 318-335
13 Lindberg M C. Hepatobiliary complications of oral contraceptives. J Gen Intern Med . 1992; 7 199-209
14 Zimmerman H J, Ishak K G. Hepatic injury due to drugs and toxins. In: MacSween RNM, Anthony PP, Scheuer PJ, et al., eds. Pathology of the Liver, 4th ed Edinburgh: Churchill Livingstone 2002: 621-710
15 Davies M H, Harrison R F, Elias E. Antibiotic-associated with severe, prolonged, intrahepatic cholestasis. J Hepatol . 1994; 20 112-116
16 Desmet V J. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol . 1997; 26(Suppl 1) 31-35
17 Geubel A P, Nakad A, Rahier J. Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction?. Liver . 1988; 8 350-353
18 Jones E A, Bergasa N V. The pruritus of cholestasis. Hepatology . 1999; 29 1003-1006
19 Granco J. Pruritus. Curr Treat Options Gastroenterol . 1999; 2 451-456